Proof of concept study to evaluate single and chronic dosing effects of ultra-long acting bronchodilator therapy on mannitol challenge in asthmatic patients taking inhaled corticosteroids
Phase of Trial: Phase IV
Latest Information Update: 23 Mar 2017
Price : $35 *
At a glance
- Drugs Indacaterol (Primary) ; Tiotropium bromide (Primary)
- Indications Allergic asthma
- Focus Proof of concept; Therapeutic Use
- 23 Mar 2017 Status changed from recruiting to completed.
- 04 Nov 2015 Accrual to date is 80% according to United Kingdom Clinical Research Network.
- 30 Sep 2015 Accrual to date is 72% according to United Kingdom Clinical Research Network record.